WebMay 12, 2024 · bluebird bio, Inc. (NASDAQ:BLUE) Q1 2024 Results Earnings Conference Call May 11, 2024 8:00 AM ET Company Participants Ingrid Goldberg – Vice President-Investor Relations, bluebird bio, Inc. WebMar 29, 2024 · Bluebird (BLUE) delivered earnings and revenue surprises of -26.67% and 99.94%, respectively, for the quarter ended December 2024. Do the numbers hold clues …
bluebird bio, Inc. (BLUE) CEO Nick Leschly on Q1 2024 Results ...
WebMar 28, 2024 · Conference Call Calendar. Dividend Calendar. Earnings Calendar. Economic Calendar. FDA Calendar. ... Analysts estimate that bluebird bio will report an … Web4 rows · Mar 29, 2024 · bluebird bio, Inc. is expected* to report earnings on 03/29/2024 before market open. The ... memories of foden
bluebird bio 4th Quarter & Full Year 2024 Earnings Call
Webbluebird bio Inc is a clinical-stage biotechnology company that develops gene therapies for severe genetic and rare diseases. The company's gene therapy procedures aim to genetically modify a patient's cells to fundamentally correct or address the genetic basis underlying a disease. Bluebird's revenue is derived from collaboration arrangements ... WebFeb 24, 2024 · For Bluebird, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has... WebMar 29, 2024 · bluebird bio is pursuing curative gene therapies to give patients and their families more bluebird days. ... - Management to host conference call today, March 29, 2024 at. Read more. 1/18/2024. bluebird bio, Inc. Announces Pricing of $120 Million … memories of foam dlc